About: http://data.cimple.eu/news-article/a9b1d607d49c499ccb34215f685327c78de46f95fadb8326022ce2c1     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Norway will drop AstraZeneca's Covid-19 vaccine from its immunisation programme due to concerns over rare side effects, and offer Johnson & Johnson's jab only to volunteers while it remains suspended, the government announced Wednesday. Prime Minister Erna Solberg told a press conference the decision had been taken in view of the rare but serious side effects associated with the jabs, which both use the same adenovirus technology. The Johnson & Johnson vaccine was never deployed in Norway, but Solberg said the country would hold on to the doses it had already received. "We want to build up back-up stocks that we can use if infections increase or if there are failures in deliveries from other vaccine producers," Solberg told reporters. Norway becomes the second European country, after Denmark, to completely drop the AstraZeneca vaccine from its national immunisation programme over rare cases of severe blood clots in people receiving the jab. The decision follows recommendations on Monday from experts who -- like the Norwegian Institute of Public Health -- recommended dropping AstraZeneca and Johnson & Johnson's vaccines from the programme. Their report, commissioned by the Norwegian government, advised instead that volunteers should be given the opportunity to be inoculated with these vaccines. From the approximately 135,000 injections of AstraZeneca's vaccine administered in Norway up until mid-March, eight cases of severe thrombosis were reported, usually in relatively young and healthy people, with four of them being fatal. Norway suspended the AstraZeneca jab on March 11 while its side effects were studied in more detail. On April 15, Norwegian health authorities recommended dropping the vaccine from the Anglo-Swedish drugmaker, but the government chose to first set up a committee of experts to examine the risks associated with the jabs. The European Medicines Agency and the World Health Organization both recommend continued use of the vaccines, arguing that the benefits far outweigh the associated risks. phy/jll/kjl
schema:headline
  • Norway drops AstraZeneca, offers J&J to volunteers only
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...entionsConspiracy
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software